PTK2 and ovarian neoplasm: We synthesized HL142 and test its antitumor activities in OC and found that HL142 suppressed ovarian tumor growth and metastasis by inhibiting ASAP1, FAK and reversing EMT through attenuating the FAK and TGFβ pathways.